The beta-hCG+erythropoietin in acute stroke (BETAS) study: A 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial

Stroke

Volumn 41, Issue 5, 2010, Pages 927-931

  Cramer, Steven C ^a   Fitzpatrick, Camille ^a   Warren, Michael ^a   Hill, Michael D ^c   Brown, David ^b   Whitaker, Laura ^b   Ryckborst, Karla J ^c   Plon, Lawrence ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Growth factor; Recovery; Stroke treatment

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; ERYTHROPOIETIN; HEMOGLOBIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN INFARCTION SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ARREST; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETICULOCYTE COUNT; STROKE; TISSUE REPAIR;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; STROKE; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 77951768123     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.574343     Document Type: Article

References (27)

1. Cramer SC. Repairing the human brain after stroke. II. Restorative therapies. Ann Neurol. 2008;63:549-560.
2. Finklestein SP, Caday CG, Kano M, Berlove DJ, Hsu CY, Moskowitz M, Klagsbrun M. Growth factor expression after stroke. Stroke. 1990;21: III122-III124.
3. Carmichael ST. Gene expression changes after focal stroke, traumatic brain and spinal cord injuries. Curr Opin Neurol. 2003;16:699-704.
4. Kawamata T, Dietrich W, Schallert T, Gotts J, Cocke R, Benowitz L, Finklestein S. Intracisternal basic fibroblast growth factor (bFGF) enhances functional recovery and upregulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci USA. 1997;94:8179-8184. (Pubitemid 27343797)
5. Kawamata T, Ren J, Chan T, Charette M, Finklestein S. Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke. Neuroreport. 1998;9:1441-1445. (Pubitemid 28264266)
6. Kolb B, Morshead C, Gonzalez C, Kim M, Gregg C, Shingo T, Weiss S. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. J Cereb Blood Flow Metab. 2007;27:983-997. (Pubitemid 46659027)
7. Belayev L, Khoutorova L, Zhao KL, Davidoff AW, Moore AF, Cramer SC. A novel neurotrophic therapeutic strategy for experimental stroke. Brain Res. 2009;1280:117-123.
8. Shingo T, Sorokan ST, Shimazaki T, Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci. 2001;21:9733-9743. (Pubitemid 34184059)
9. Lei ZM, Rao CV. Neural actions of luteinizing hormone and human chorionic gonadotropin. Semin Reprod Med. 2001;19:103-109.
10. Lukacs H, Hiatt ES, Lei ZM, Rao CV. Peripheral and intracerebroven- tricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm Behav. 1995;29:42-58.
11. Davidoff AW, Hill MD, Cramer SC, Yang Y, Moore A. Open labeled, uncontrolled pharmacokinetic study of a single intramuscular hCG dose in healthy male volunteers. Int J Clin Pharmacol Ther. 2009;47:516-524
12. al-Hader AA, Tao YX, Lei ZM, Rao CV. Fetal rat brains contain luteinizing hormone/human chorionic gonadotropin receptors. Early Pregnancy. 1997;3:323-329.
13. Chen J, Chopp M. Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx. 2006;3:466-473. (Pubitemid 44443015)
14. Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006;354:2034-2045.
15. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA. 1995;92: 3717-3720.
16. Cramer SC, Koroshetz WJ, Finklestein SP. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke. 2007;38:1393-1395.
17. Yozbatiran N, Der-Yeghiaian L, Cramer SC. A standardized approach to performing the action research arm test. Neurorehabil Neural Repair. 2008;22:78-90. (Pubitemid 350223140)
18. Fugl-Meyer A, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient: a method for evaluation of physical performance. Scand J Rehabil Med. 1975;7:13-31.
19. Kent PS, Luszcz MA. A review of the Boston Naming Test and multiple-occasion normative data for older adults on 15-item versions. Clin Neu-ropsychol. 2002;16:555-574.
20. Albert ML. A simple test of visual neglect. Neurology. 1973;23:658-664.
21. Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol. 1955;19:393-394.
22. Beck AT, Beck RW. Screening depressed patients in family practice. A rapid technic. Postgrad Med. 1972;52:81-85.
23. Uchino K, Billheimer D, Cramer S. Entry criteria and baseline characteristics predict outcome in acute stroke trials. Stroke. 2001;32:909-916. (Pubitemid 32285160)
24. Warach S, Kaufman D, Chiu D, Devlin T, Luby M, Rashid A, Clayton L, Kaste M, Lees KR, Sacco R, Fisher M. Effect of the glycine antagonist gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: the GAIN MRI substudy. Cerebrovasc Dis. 2006;21:106-111. (Pubitemid 43110319)
25. Fishbane S, Nissenson AR. The new FDA label for erythropoietin treatment: how does it affect hemoglobin target? Kidney Int. 2007;72: 806-813. (Pubitemid 47462071)
26. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jahnig P, Herrmann M, Knauth M, Bahr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40:e647-e656.
27. Hillis A, Wityk R, Barker P, Beauchamp N, Gailloud P, Murphy K, Cooper O, Metter E. Subcortical aphasia and neglect in acute stroke: the role of cortical hypoperfusion. Brain. 2002;125:1094-1104. (Pubitemid 34464620)